Interval debulking surgery with or without hyperthermic intraperitoneal chemotherapy in advanced-stage ovarian cancer: single-institution cohort study

HIGHLIGHTS

  • who: Yong Jae Lee et al. from the (IRB) at Severance Hospital, Yonsei University Health SystemUniversity of Udine, Italy have published the paper: Interval debulking surgery with or without hyperthermic intraperitoneal chemotherapy in advanced-stage ovarian cancer: Single-institution cohort study, in the Journal: (JOURNAL)
  • what: The aim of this study is to evaluate the outcomes of the addition of HIPEC to IDS in patients with advanced-stage ovarian cancer.
  • future: Studies are needed to evaluate the true place of HIPEC in the current era of targeted treatment.

SUMMARY

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?